Anaveon
Andreas Katopodis is the co-founder and CEO of Anaveon, a biotech company focused on developing treatments for autoimmune diseases. Prior to founding Anaveon, they were a director at Novartis Institutes of Biomedical Research.
Some direct reports include Christoph Huber - Chief Scientific Officer, Christine Wurz - Senior Quality Assurance Director, and Arkadi Khait - Head of Finance.
Anaveon
1 followers
Anaveon is a developing IL-2 complexes which selectively promote effector T cell functions.